| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Revenue | $2.54B | +18.1% |
| Cost of Revenue | $334.8M | +3.3% |
| Gross Profit | $2.20B | +20.7% |
| R&D Expense | $736.8M | +15.3% |
| SG&A Expense | $237.3M | +18.1% |
| Operating Income | $172.5M | +2181.4% |
| Pre-tax Income | $211.6M | +308.9% |
| Income Tax | $23.3M | -0.7% |
| Net Income | $188.4M |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $769.5M | +17.4% |
| Accounts Receivable | $338.0M | +47.1% |
| Current Assets | $2.59B | +74.8% |
| Total Assets | $3.28B | +53.1% |
| Current Liabilities | $1.41B | +13.6% |
| Total Liabilities | $3.98B | +38.5% |
| Stockholders' Equity | -$694.5M | +4.6% |
| Line Item | 2025-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $821.5M | +22.1% |
| Capital Expenditures | $71.3M | -5.3% |
| Investing Cash Flow | -$951.7M | -279.7% |
| Financing Cash Flow | $244.1M | +123.0% |
| Free Cash Flow | $750.2M | +25.5% |
| +251.0% |
| EPS (Basic) | $0.70 | +237.3% |
| EPS (Diluted) | $0.65 | +227.5% |